9.74
3.73%
0.35
アフターアワーズ:
9.75
0.010
+0.10%
前日終値:
$9.39
開ける:
$9.53
24時間の取引高:
482.52K
Relative Volume:
1.36
時価総額:
$311.42M
収益:
$2.07M
当期純損益:
$-47.68M
株価収益率:
-2.9515
EPS:
-3.3
ネットキャッシュフロー:
$-31.31M
1週間 パフォーマンス:
-2.21%
1か月 パフォーマンス:
-13.65%
6か月 パフォーマンス:
+28.67%
1年 パフォーマンス:
+297.55%
Delcath Systems Inc Stock (DCTH) Company Profile
名前
Delcath Systems Inc
セクター
電話
(518) 743-8892
住所
566 QUEENSBURY AVENUE, QUEENSBURY, NY
DCTH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
DCTH | 9.74 | 311.42M | 2.07M | -47.68M | -31.31M | -3.30 |
ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2022-07-26 | 再開されました | Canaccord Genuity | Buy |
2021-12-10 | 開始されました | H.C. Wainwright | Buy |
2021-03-09 | 開始されました | Canaccord Genuity | Buy |
2021-01-05 | 開始されました | BTIG Research | Buy |
2020-06-01 | 開始されました | Laidlaw | Buy |
Delcath Systems Inc (DCTH) 最新ニュース
Delcath Systems: Q3 Earnings Reveal HEPZATO KIT And CHEMOSAT Growth (NASDAQ:DCTH) - Seeking Alpha
(DCTH) Investment Analysis - Stock Traders Daily
Delcath Systems Stock (NASDAQ:DCTH) Among the Best Multibagger Stock to Buy Heading into 2025 - Insider Monkey
Rosalind Advisors, Inc. Increases Stake in Delcath Systems Inc - GuruFocus.com
10 Best Multibagger Stocks To Buy Heading into 2025 - Insider Monkey
Intrahepatic Cholangiocarcinoma Treatment Market size is expected to grow owing to the launch of emerging therapies by 2034, estimates DelveInsight - Barchart
FY2024 EPS Estimate for Delcath Systems Raised by Analyst - MarketBeat
FY2028 EPS Forecast for Delcath Systems Decreased by Analyst - MarketBeat
Uveal melanoma Treatment Market Countermeasures Of Economic - openPR
HC Wainwright Reiterates Buy Rating for Delcath Systems (NASDAQ:DCTH) - MarketBeat
Delcath Systems revenue hits USD 11.2M in Q3 2024, a 44% increase - Medical Buyer
Delcath Systems Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Delcath Systems stock soars to 52-week high of $12 amid robust gains - Investing.com Australia
Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Highlights: Str - GuruFocus.com
Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Delcath Systems, Inc. (NASDAQ:DCTH) Q3 2024 Earnings Call Transcript - Insider Monkey
Delcath Systems Reports Strong Q3 Growth and Expansion - TipRanks
Delcath Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Wall Street Analysts Believe Delcath Systems (DCTH) Could Rally 96.84%: Here's is How to Trade - MSN
Delcath Systems Inc (DCTH) Q3 2024 Earnings: Revenue Surpasses E - GuruFocus.com
Delcath Systems, Inc. (DCTH) Reports Q3 Loss - Yahoo Finance
Delcath Systems Revenue Surges 44% to $11.2M as HEPZATO Launch Gains Momentum | DCTH Stock News - StockTitan
Uncovering Potential: Delcath Systems's Earnings Preview - Benzinga
(DCTH) Investment Analysis and Advice - Stock Traders Daily
Delcath Systems (DCTH) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
Delcath Systems, Inc. (DCTH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - MSN
Delcath Systems to Participate in Upcoming Investor Conferences - StockTitan
Delcath Systems, Inc.'s (NASDAQ:DCTH) P/S Is Still On The Mark Following 26% Share Price Bounce - Simply Wall St
Comparing Cell MedX (OTCMKTS:CMXC) & Delcath Systems (NASDAQ:DCTH) - Defense World
Delcath Systems (DCTH) to Release Quarterly Earnings on Friday - MarketBeat
Delcath Systems (DCTH) Scheduled to Post Quarterly Earnings on Friday - Defense World
(DCTH) Pivots Trading Plans and Risk Controls - Stock Traders Daily
DCTHDelcath Systems Inc Latest Stock News & Market Updates - StockTitan
Delcath Systems to Host Third Quarter 2024 Earnings Call - StockTitan
Delcath Systems (NASDAQ:DCTH) Upgraded to "Hold" at StockNews.com - MarketBeat
Delcath Systems Inc (DCTH) Trading 3.48% Higher on Oct 22 - GuruFocus.com
Delcath Systems (NASDAQ:DCTH) Rating Lowered to Sell at StockNews.com - Defense World
Delcath shares rise on record sales, analyst reiterates buy rating By Investing.com - Investing.com UK
Analyst Scoreboard: 4 Ratings For Delcath Systems - Benzinga
Delcath shares rise on strong 3Q sales, analyst reiterates buy - Investing.com
Delcath shares rise on strong 3Q sales, analyst reiterates buy By Investing.com - Investing.com South Africa
Delcath Systems' (DCTH) "Buy" Rating Reiterated at Canaccord Genuity Group - MarketBeat
Delcath Systems revenue hits USD 11.2M in Q3 2024 - Medical Buyer
StockNews.com Lowers Delcath Systems (NASDAQ:DCTH) to Sell - MarketBeat
Delcath triggers $25 million financing with Q3 revenue - Investing.com
Delcath Systems, Inc. Announces Preliminary Revenue Results for the Third Quarter of 2024 - Marketscreener.com
Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results - StockTitan
Bullish Delcath Systems Insiders Rewarded As Their Investment Rises To US$1.94m - Simply Wall St
When the Price of (DCTH) Talks, People Listen - Stock Traders Daily
Delcath Systems, Inc. (NASDAQ:DCTH) Short Interest Update - MarketBeat
Intrahepatic Cholangiocarcinoma Market Report 2034 | - openPR
Delcath Systems Inc (DCTH) 財務データ
収益
当期純利益
現金流量
EPS
Delcath Systems Inc (DCTH) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Aharon Gil | Director |
Mar 19 '24 |
Buy |
3.72 |
26,882 |
100,001 |
1,069,710 |
SALAMON STEVEN A J | Director |
Mar 19 '24 |
Buy |
3.72 |
26,882 |
100,001 |
1,121,025 |
Vukovic Vojo | Chief Medical Officer |
Dec 12 '23 |
Buy |
3.00 |
40,000 |
120,000 |
100,000 |
MICHEL GERARD J | Chief Executive Officer |
Dec 08 '23 |
Buy |
2.94 |
34,000 |
99,960 |
262,345 |
大文字化:
|
ボリューム (24 時間):